BioSpace News Archive

BioForest

The Leapfrog Group Wins Health Value Award for Groundbreaking “Lives and Dollars Lost” Calculator

The Leapfrog Group, a national watchdog organization of employers and other purchasers focused on health care safety and quality, last night accepted the 2019 Health Value Award for Value Transparency Services in recognition of its “Lives and Dollars Lost to Medical Errors” calculator.

June 11, 2019
·
2 min read
BioForest

Pediatric CAR T-Cell Immunotherapy Trial Aims to Improve Remission Rates of Leukemia at Children’s National Health System

Children’s National Health System announced the opening of a unique chimeric antigen receptor T-cell immunotherapy trial for pediatric patients with relapsed positive acute lymphoblastic leukemia.

June 11, 2019
·
4 min read
Business

SaaS Industry Veteran David Justus Joins Kareo as CFO To Support Rapid Growth

Kareo Further Strengthens Board of Directors with Appointment of Scott Maxwell and David Cozzens

June 11, 2019
·
3 min read
Business

Thommen Medical USA Announces Leadership Changes To Drive New Market Position

Thommen Medical USA, a leading Swiss manufacturer of dental implant solutions, announces that it has a new leadership team.

June 11, 2019
·
3 min read
Business

Liberty Health Sciences Continues Rapid Expansion In FL With The Opening Of Its 15ᵗʰ Dispensary In Boca Raton

Liberty Health Sciences Inc. announced that it will open its 15th dispensary in the city of Boca Raton on June 20, which will also be Liberty’s first dispensary located in Palm Beach County, subject to approval from the Florida Department of Health.

June 11, 2019
·
4 min read
Mallinckrodt to Present at BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

Mallinckrodt Pharmaceuticals, a global biopharmaceutical company, will present on Tuesday, June 25, 2019, at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference at the Mandarin Oriental, 80 Columbus Circle, New York.

June 11, 2019
·
2 min read
FDA

FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab)

KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Monotherapy for Patients Whose Tumors Express PD-L1 (CPS ≥1) or in Combination with Platinum and Fluorouracil (FU) Regardless of PD-L1 Expression

June 11, 2019
·
40 min read
Policy

Opsens Solutions Further Expands Intellectual Property Portfolio with USPTO Grant

Opsens Inc. announced that its wholly-owned subsidiary Opsens Solutions Inc., has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office.

June 11, 2019
·
2 min read
Deals

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results

Global Cord Blood Corporation announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 on Tuesday, June 18, 2019, after the market close.

June 11, 2019
·
2 min read
Deals

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2019

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2019.

June 11, 2019
·
1 min read